Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting

BACKGROUND: Limited data exists comparing the safety, tolerability, and efficacy of direct-acting antivirals (DAAs) in patients with chronic hepatitis C genotype 4 (HCV GT-4) in the community practice setting. We aim to evaluate the treatment response of DAAs in these patients. METHODS: All the HCV...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gastroenterology Res
Auteurs principaux: Gayam, Vijay, Khalid, Mazin, Mandal, Amrendra Kumar, Hussain, Muhammad Rajib, Mukhtar, Osama, Gill, Arshpal, Garlapati, Pavani, Shrestha, Binav, Guss, Debra, Sherigar, Jagannath, Mansour, Mohammed, Mohanty, Smruti
Format: Artigo
Langue:Inglês
Publié: Elmer Press 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916637/
https://ncbi.nlm.nih.gov/pubmed/29707080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/gr999w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires